Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.7B | 5.7B | 6.8B | 6.6B |
Cost of revenue | 4.2B | 4.3B | 4.7B | 4.4B |
Gross profit | 1.5B | 1.4B | 2.1B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 154M | 129M | 117M | 123M |
Other operating expenses | 49M | 53M | 58M | 68M |
Operating income | 1.3B | 1.2B | 1.9B | 2.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 70M | 70M | 72M | 88M |
Other income expense | 58M | 67M | 97M | 69M |
Pretax income | 1.3B | 1.2B | 2.0B | 2.0B |
Tax provision | 500M | 520M | 737M | 754M |
Net income | 793M | 721M | 1.2B | 1.3B |
Basic EPS | 0.2 | 0.2 | 0.4 | 0.4 |
Diluted EPS | 0.2 | 0.2 | 0.4 | 0.4 |
Basic average shares | 1.4B | 1.4B | 1.4B | 1.4B |
Diluted average shares | 1.4B | 1.4B | 1.4B | 1.4B |
EBITDA | 1.8B | 1.8B | 2.6B | 2.6B |
Net income from continuing op. | 793M | 721M | 1.2B | 1.3B |
Minority interests | -441M | -447M | -710M | -664M |
Preferred stock dividends | — | — | — | — |